Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 215

1.

A Retrospective Claims Analysis of Dual Bronchodilator Fixed-Dose Combination Versus Bronchodilator Monotherapy in Patients with Chronic Obstructive Pulmonary Disease.

Strange C, Walker V, Tong J, Kurlander J, Carlyle M, Millette LA, Wittbrodt E.

Chronic Obstr Pulm Dis. 2019 Jul 24;6(3):221-232. doi: 10.15326/jcopdf.6.3.2018.0160.

2.

Patient-reported outcomes of dual bronchodilator fixed-dose combination versus bronchodilator monotherapy in individuals with COPD.

Strange C, Walker V, DePietro M, Tong J, Kurlander J, Carlyle M, Millette LA, Wittbrodt E.

Int J Chron Obstruct Pulmon Dis. 2019 Jun 28;14:1377-1388. doi: 10.2147/COPD.S194856. eCollection 2019.

3.

Clathrin-mediated Endocytosis of Alpha-1 Antitrypsin is Essential for its Protective Function in Islet Cell Survival.

Wang J, Gou W, Kim DS, Strange C, Wang H.

Theranostics. 2019 May 31;9(13):3940-3951. doi: 10.7150/thno.31647. eCollection 2019.

4.

Evidence-Based Medicine and the American Thoracic Society Guidelines.

Dweik RA, Strange C, Wilson KC.

JAMA Intern Med. 2019 Jul 1;179(7):1003-1004. doi: 10.1001/jamainternmed.2019.1867. No abstract available.

PMID:
31260016
5.

Rare Disease Registries: Steps Forward.

Strange C.

Chronic Obstr Pulm Dis. 2019 Apr;6(2):126-128. doi: 10.15326/jcopdf.6.2.2019.0133. No abstract available.

6.

Evaluating fluticasone furoate + vilanterol for the treatment of chronic obstructive pulmonary disease (COPD).

Lal C, Strange C.

Expert Opin Pharmacother. 2019 Jun;20(9):1075-1085. doi: 10.1080/14656566.2019.1603292. Epub 2019 Apr 14.

PMID:
30983423
7.

Analysis of the MILES cohort reveals determinants of disease progression and treatment response in lymphangioleiomyomatosis.

Gupta N, Lee HS, Young LR, Strange C, Moss J, Singer LG, Nakata K, Barker AF, Chapman JT, Brantly ML, Stocks JM, Brown KK, Lynch JP 3rd, Goldberg HJ, Downey GP, Taveira-DaSilva AM, Krischer JP, Setchell K, Trapnell BC, Inoue Y, McCormack FX; NIH Rare Lung Disease Consortium.

Eur Respir J. 2019 Apr 4;53(4). pii: 1802066. doi: 10.1183/13993003.02066-2018. Print 2019 Apr.

PMID:
30846465
8.

Predictors of Response to Endobronchial Coil Therapy in Patients With Advanced Emphysema.

Slebos DJ, Cicenia J, Sciurba FC, Criner GJ, Hartman JE, Garner J, Deslée G, Delage A, Jantz M, Marquette CH, Strange C, Hatipoglu U, Mehta AC, LaPrad AS, Schmid-Bindert G, Herth FJF, Shah PL; RENEW Study Group.

Chest. 2019 May;155(5):928-937. doi: 10.1016/j.chest.2019.02.012. Epub 2019 Feb 21.

PMID:
30797746
9.

Use of a Cross-Sectional Survey in the Adult Population to Characterize Persons at High-Risk for Chronic Obstructive Pulmonary Disease.

Pleasants RA, Heidari K, Ohar J, Donohue JF, Lugogo N, Richard CL, Kanotra S, Mannino DM, Kraft M, Liao W, Strange C.

Healthcare (Basel). 2019 Jan 18;7(1). pii: E12. doi: 10.3390/healthcare7010012.

10.

A qualitative evaluation of a Young Parents Program (YPP) - Parent and facilitator perspectives.

Strange C, Bennett E, Tait M, Hauck Y.

Health Promot J Austr. 2018 Dec 29. doi: 10.1002/hpja.228. [Epub ahead of print]

PMID:
30597660
11.

Lectin Complement Pathway in Emphysema.

Serban KA, Mikosz A, Strange C, Janciauskiene SM, Stolk J, Jonigk D, Sandhaus RA, Petrache I.

Am J Respir Crit Care Med. 2019 Mar 1;199(5):659-661. doi: 10.1164/rccm.201807-1380LE. No abstract available.

PMID:
30557515
12.

T-blocker: a simple and robust probe-free quantitative PCR assay to detect somatic mutations down to 0.1% frequency.

Kim H, Ruby AE, Shandilya HG, Virmani AK, Rahman N, Strange CM, Huuskonen J.

Biotechniques. 2018 Oct;65(4):205-210. doi: 10.2144/btn-2018-0111.

13.

Sequencing Alpha-1 MZ Individuals Shows Frequent Biallelic Mutations.

Foil KE, Blanton MG, Sanders C, Kim J, Al Ashry HS, Kumbhare S, Strange C.

Pulm Med. 2018 Sep 5;2018:2836389. doi: 10.1155/2018/2836389. eCollection 2018.

14.

Oropharyngeal swallow physiology and swallowing-related quality of life in underweight patients with concomitant advanced chronic obstructive pulmonary disease.

Garand KL, Strange C, Paoletti L, Hopkins-Rossabi T, Martin-Harris B.

Int J Chron Obstruct Pulmon Dis. 2018 Aug 29;13:2663-2671. doi: 10.2147/COPD.S165657. eCollection 2018.

15.

Inhaled corticosteroids for chronic obstructive pulmonary disease: what is their role in therapy?

Tashkin DP, Strange C.

Int J Chron Obstruct Pulmon Dis. 2018 Aug 27;13:2587-2601. doi: 10.2147/COPD.S172240. eCollection 2018. Review.

16.

Therapeutic Effects of Adipose Stem Cells from Diabetic Mice for the Treatment of Type 2 Diabetes.

Wang M, Song L, Strange C, Dong X, Wang H.

Mol Ther. 2018 Aug 1;26(8):1921-1930. doi: 10.1016/j.ymthe.2018.06.013. Epub 2018 Jun 19.

17.

Proteomic biomarkers of cognitive impairment in obstructive sleep apnea syndrome.

Lal C, Hardiman G, Kumbhare S, Strange C.

Sleep Breath. 2019 Mar;23(1):251-257. doi: 10.1007/s11325-018-1693-8. Epub 2018 Jul 2.

PMID:
29968150
18.

Anti-Proteases and Alpha-1 Antitrypsin Augmentation Therapy.

Strange C.

Respir Care. 2018 Jun;63(6):690-698. doi: 10.4187/respcare.05933. Review.

19.

Mortality in Asthma-Chronic Obstructive Pulmonary Disease Overlap in the United States.

Kumbhare S, Strange C.

South Med J. 2018 May;111(5):293-298. doi: 10.14423/SMJ.0000000000000807.

PMID:
29767222
20.

Increasing multimorbidity in an Australian street health service: A 10-year retrospective cohort study

Arnold-Reed D, Troeung L, Brett T, Chan She Ping-Delfos W, Strange C, Geelhoed E, Fisher C, Preen D.

Aust J Gen Pract. 2018 Apr;47(4):181-189.

21.

A general practice street health service

Strange C, Fisher C, Ping-Delfos WCS, Arnold-Reed D, Brett T.

Aust J Gen Pract. 2018 Jan-Feb;47(1-2):44-49.

22.

Autologous Mesenchymal Stem Cell and Islet Cotransplantation: Safety and Efficacy.

Wang H, Strange C, Nietert PJ, Wang J, Turnbull TL, Cloud C, Owczarski S, Shuford B, Duke T, Gilkeson G, Luttrell L, Hermayer K, Fernandes J, Adams DB, Morgan KA.

Stem Cells Transl Med. 2018 Jan;7(1):11-19. doi: 10.1002/sctm.17-0139. Epub 2017 Nov 21.

23.

Lymphangioleiomyomatosis Diagnosis and Management: High-Resolution Chest Computed Tomography, Transbronchial Lung Biopsy, and Pleural Disease Management. An Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guideline.

Gupta N, Finlay GA, Kotloff RM, Strange C, Wilson KC, Young LR, Taveira-DaSilva AM, Johnson SR, Cottin V, Sahn SA, Ryu JH, Seyama K, Inoue Y, Downey GP, Han MK, Colby TV, Wikenheiser-Brokamp KA, Meyer CA, Smith K, Moss J, McCormack FX; ATS Assembly on Clinical Problems.

Am J Respir Crit Care Med. 2017 Nov 15;196(10):1337-1348. doi: 10.1164/rccm.201709-1965ST.

24.

A review of current and developing fixed-dose LABA/LAMA combinations for treating COPD.

Lal C, Strange C.

Expert Opin Pharmacother. 2017 Dec;18(17):1833-1843. doi: 10.1080/14656566.2017.1403583. Epub 2017 Nov 15. Review.

PMID:
29115881
25.

COPD in individuals with the PiMZ alpha-1 antitrypsin genotype.

Al Ashry HS, Strange C.

Eur Respir Rev. 2017 Oct 25;26(146). pii: 170068. doi: 10.1183/16000617.0068-2017. Print 2017 Dec 31. Review.

26.

Use of multitarget tyrosine kinase inhibitors to attenuate platelet-derived growth factor signalling in lung disease.

Kanaan R, Strange C.

Eur Respir Rev. 2017 Oct 25;26(146). pii: 170061. doi: 10.1183/16000617.0061-2017. Print 2017 Dec 31. Review.

27.

Adipose stem cells from chronic pancreatitis patients improve mouse and human islet survival and function.

Song L, Sun Z, Kim DS, Gou W, Strange C, Dong H, Cui W, Gilkeson G, Morgan KA, Adams DB, Wang H.

Stem Cell Res Ther. 2017 Aug 30;8(1):192. doi: 10.1186/s13287-017-0627-x.

28.

Adipose Stem Cell Therapy Mitigates Chronic Pancreatitis via Differentiation into Acinar-like Cells in Mice.

Sun Z, Gou W, Kim DS, Dong X, Strange C, Tan Y, Adams DB, Wang H.

Mol Ther. 2017 Nov 1;25(11):2490-2501. doi: 10.1016/j.ymthe.2017.06.016. Epub 2017 Aug 4.

29.

Differences in Right Ventricular Functional Changes during Treatment between Systemic Sclerosis-associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension.

Argula RG, Karwa A, Lauer A, Gregg D, Silver RM, Feghali-Bostwick C, Schanpp LM, Egbert K, Usher BW, Ramakrishnan V, Hassoun PM, Strange C.

Ann Am Thorac Soc. 2017 May;14(5):682-689. doi: 10.1513/AnnalsATS.201608-655OC.

30.

Spotlight on fluticasone furoate/umeclidinium/vilanterol in COPD: design, development, and potential place in therapy.

Lal C, Strange C.

Int J Chron Obstruct Pulmon Dis. 2016 Dec 30;12:135-140. doi: 10.2147/COPD.S114273. eCollection 2017. Review.

31.

α-1 Antitrypsin Enhances Islet Engraftment by Suppression of Instant Blood-Mediated Inflammatory Reaction.

Wang J, Sun Z, Gou W, Adams DB, Cui W, Morgan KA, Strange C, Wang H.

Diabetes. 2017 Apr;66(4):970-980. doi: 10.2337/db16-1036. Epub 2017 Jan 9.

32.

Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management.

McCormack FX, Gupta N, Finlay GR, Young LR, Taveira-DaSilva AM, Glasgow CG, Steagall WK, Johnson SR, Sahn SA, Ryu JH, Strange C, Seyama K, Sullivan EJ, Kotloff RM, Downey GP, Chapman JT, Han MK, D'Armiento JM, Inoue Y, Henske EP, Bissler JJ, Colby TV, Kinder BW, Wikenheiser-Brokamp KA, Brown KK, Cordier JF, Meyer C, Cottin V, Brozek JL, Smith K, Wilson KC, Moss J; ATS/JRS Committee on Lymphangioleiomyomatosis.

Am J Respir Crit Care Med. 2016 Sep 15;194(6):748-61. doi: 10.1164/rccm.201607-1384ST.

33.

Local community playgroup participation and associations with social capital.

Strange C, Bremner A, Fisher C, Howat P, Wood L.

Health Promot J Austr. 2017 Aug;28(2):110-117. doi: 10.1071/HE15134.

PMID:
27498710
34.

Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial.

Tashkin DP, Roth MD, Clements PJ, Furst DE, Khanna D, Kleerup EC, Goldin J, Arriola E, Volkmann ER, Kafaja S, Silver R, Steen V, Strange C, Wise R, Wigley F, Mayes M, Riley DJ, Hussain S, Assassi S, Hsu VM, Patel B, Phillips K, Martinez F, Golden J, Connolly MK, Varga J, Dematte J, Hinchcliff ME, Fischer A, Swigris J, Meehan R, Theodore A, Simms R, Volkov S, Schraufnagel DE, Scholand MB, Frech T, Molitor JA, Highland K, Read CA, Fritzler MJ, Kim GHJ, Tseng CH, Elashoff RM; Sclerodema Lung Study II Investigators.

Lancet Respir Med. 2016 Sep;4(9):708-719. doi: 10.1016/S2213-2600(16)30152-7. Epub 2016 Jul 25.

35.

Thermal vapour ablation to reduce segmental volume in patients with severe emphysema: STEP-UP 12 month results.

Shah PL, Gompelmann D, Valipour A, McNulty WH, Eberhardt R, Grah C, Egan J, Ficker JH, Wagner M, Witt C, Liebers U, Hopkins P, Gesierich W, Phillips M, Stanzel F, Petermann C, Strange C, Snell G, Herth FJF.

Lancet Respir Med. 2016 Sep;4(9):e44-e45. doi: 10.1016/S2213-2600(16)30199-0. Epub 2016 Jul 20. No abstract available.

PMID:
27451345
36.

Reply: Asthma/COPD Overlap Syndrome and Medicare 30-Day Readmissions.

Strange C, Kumbhare S.

Ann Am Thorac Soc. 2016 Jul;13(7):1192. doi: 10.1513/AnnalsATS.201604-269LE. No abstract available.

PMID:
27388414
37.

The Diagnosis and Management of Alpha-1 Antitrypsin Deficiency in the Adult.

Sandhaus RA, Turino G, Brantly ML, Campos M, Cross CE, Goodman K, Hogarth DK, Knight SL, Stocks JM, Stoller JK, Strange C, Teckman J.

Chronic Obstr Pulm Dis. 2016 Jun 6;3(3):668-682. doi: 10.15326/jcopdf.3.3.2015.0182. Review.

38.

Effect of Endobronchial Coils vs Usual Care on Exercise Tolerance in Patients With Severe Emphysema: The RENEW Randomized Clinical Trial.

Sciurba FC, Criner GJ, Strange C, Shah PL, Michaud G, Connolly TA, Deslée G, Tillis WP, Delage A, Marquette CH, Krishna G, Kalhan R, Ferguson JS, Jantz M, Maldonado F, McKenna R, Majid A, Rai N, Gay S, Dransfield MT, Angel L, Maxfield R, Herth FJ, Wahidi MM, Mehta A, Slebos DJ; RENEW Study Research Group.

JAMA. 2016 May 24-31;315(20):2178-89. doi: 10.1001/jama.2016.6261.

39.

Gender and asthma-chronic obstructive pulmonary disease overlap syndrome.

Wheaton AG, Pleasants RA, Croft JB, Ohar JA, Heidari K, Mannino DM, Liu Y, Strange C.

J Asthma. 2016 Sep;53(7):720-31. doi: 10.3109/02770903.2016.1154072. Epub 2016 Apr 6.

40.

Characteristics of COPD Patients Using United States Emergency Care or Hospitalization.

Kumbhare SD, Beiko T, Wilcox SR, Strange C.

Chronic Obstr Pulm Dis. 2016 Mar 28;3(2):539-548. doi: 10.15326/jcopdf.3.2.2015.0155.

41.

Health Care Utilization and Costs After Initiating Budesonide/Formoterol Combination or Fluticasone/Salmeterol Combination Among COPD Patients New to ICS/LABA Treatment.

Davis JR, Kern DM, Williams SA, Tunceli O, Wu B, Hollis S, Strange C, Trudo F.

J Manag Care Spec Pharm. 2016 Mar;22(3):293-304. doi: 10.18553/jmcp.2016.22.3.293.

42.

Characteristics and Prevalence of Asthma/Chronic Obstructive Pulmonary Disease Overlap in the United States.

Kumbhare S, Pleasants R, Ohar JA, Strange C.

Ann Am Thorac Soc. 2016 Jun;13(6):803-10. doi: 10.1513/AnnalsATS.201508-554OC.

PMID:
26974689
43.

A Novel Quantitative Computed Tomographic Analysis Suggests How Sirolimus Stabilizes Progressive Air Trapping in Lymphangioleiomyomatosis.

Argula RG, Kokosi M, Lo P, Kim HJ, Ravenel JG, Meyer C, Goldin J, Lee HS, Strange C, McCormack FX; MILES Study Investigators.

Ann Am Thorac Soc. 2016 Mar;13(3):342-9. doi: 10.1513/AnnalsATS.201509-631OC.

44.

Respiratory and lower limb muscle function in interstitial lung disease.

Panagiotou M, Polychronopoulos V, Strange C.

Chron Respir Dis. 2016 May;13(2):162-72. doi: 10.1177/1479972315626014. Epub 2016 Jan 14. Review.

45.

Rapid oral desensitization to sirolimus in a patient with lymphangioleiomyomatosis.

Sebaaly J, Bowers L, Mazur J, Kotloff R, Olmsted BR, Kaplan A, Strange C.

J Allergy Clin Immunol Pract. 2016 Mar-Apr;4(2):352-3. doi: 10.1016/j.jaip.2015.11.007. Epub 2015 Dec 24. No abstract available.

PMID:
26725158
46.

Comparative effectiveness of budesonide/formoterol combination and tiotropium bromide among COPD patients new to these controller treatments.

Trudo F, Kern DM, Davis JR, Tunceli O, Zhou S, Graham EL, Strange C, Williams SA.

Int J Chron Obstruct Pulmon Dis. 2015 Sep 28;10:2055-66. doi: 10.2147/COPD.S90658. eCollection 2015.

47.

Patterns of Emphysema Heterogeneity.

Valipour A, Shah PL, Gesierich W, Eberhardt R, Snell G, Strange C, Barry R, Gupta A, Henne E, Bandyopadhyay S, Raffy P, Yin Y, Tschirren J, Herth FJ.

Respiration. 2015;90(5):402-11. doi: 10.1159/000439544. Epub 2015 Oct 3.

48.

Mothers' group participation: associations with social capital, social support and mental well-being.

Strange C, Bremner A, Fisher C, Howat P, Wood L.

J Adv Nurs. 2016 Jan;72(1):85-98. doi: 10.1111/jan.12809. Epub 2015 Sep 29.

PMID:
26420352
49.

Impact of obstructive sleep apnea syndrome on cognition in early postmenopausal women.

Lal C, DiBartolo MM, Kumbhare S, Strange C, Joseph JE.

Sleep Breath. 2016 May;20(2):621-6. doi: 10.1007/s11325-015-1261-4. Epub 2015 Sep 18.

PMID:
26385776
50.

Targeting Persons With or At High Risk for Chronic Obstructive Pulmonary Disease by State-based Surveillance.

Pleasants RA, Heidari K, Wheaton AG, Ohar JA, Strange C, Croft JB, Liao W, Mannino DM, Kraft M.

COPD. 2015;12(6):680-9. doi: 10.3109/15412555.2015.1043424. Epub 2015 Sep 14.

Supplemental Content

Loading ...
Support Center